Skip to main content
FDA approves neoadjuvant pembro for triple-negative breast cancer
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves neoadjuvant pembro for triple-negative breast cancer
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Triple Negative Breast Cancer
0
0.99
Biologic Therapy
0
0.65
Breast
0
0.49
Cancer
0
0.49
Neoadjuvant Therapy
0
0.37
Dermatitis
0
0.33
Id Reaction
0
0.3
Immunotherapy
0
0.24
Surgery
0
0.24
Chemotherapy
0
0.18
Tumor
0
0.18
Combination Chemotherapy
0
0.17
Brachial
0
0.12
Food and Drug Administration (FDA)
0
0.95
Pregnancy
0
0.07
Clinical Research
0
0.06
Corticosteroids
0
0.06
Europe
0
0.06
Single-Agent Therapy
0
0.06
Tissue
0
0.06
Specialty
Lead
score
Hematology-Oncology
1
1